CBC Saskatchewan

  | Bookmark and Share

First person selected for MS trials

Andrew Dahlen is the first person from Saskatchewan selected to go to Albany, New York for clinical trials of a controversial neck vein therapy treatment that may help multiple sclerosis patients.
Download Flash Player to view this content.
  •